GB Meka
Stocks to watch

GLUE

Compare

Monte Rosa Therapeutics Inc · Healthcare

$12.02
▲ 2.4%Close 2026-09-30

Live intraday price

Compare with our price levels

T215.00
T114.62
E18.94
E37.09
SL6.47

Close 2026-09-30: $12.02 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 25.6% · 1 whale recently bought

1 month
▼ 13.8%
3 months
▼ 50.0%
1 year
▲ 64.4%
Analyst target
$28.50 +137.1%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$8.94 -25.6%
E2$8.02 -33.3%
E3$7.09 -41.0%
Targets
T1$14.62 21.6%
T2$15.00 24.8%
T3$15.55 29.3%
Stop-loss
SL$6.47 -46.2%
Whale cost ~$19.35 61.0%

Risk : reward 1 : 4.5Moves ~$0.62 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●MACD เพิ่งตัดขึ้น (โมเมนตัมเริ่มกลับเป็นบวก)
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 28.50 (upside +137%, 6 ราย)
! Risks (4)
  • ●แนวโน้มระยะยาวเป็นขาลง (ใต้ MA200 และ MA200 ชี้ลง)
  • ●เพิ่งเกิด Death Cross (MA50 ตัดลง MA200)
  • ●อ่อนแอกว่าตลาด (S&P 500) -46% ใน 6 เดือน
  • ●รายได้หดตัว -61% เทียบปีก่อน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Warmuth Markus · CEO · Director

2026-07-16 · 9,500 shares @ $23.18

$220,219
Sell

Champoux Jennifer · COO

2026-07-15 · 4,351 shares @ $23.38 · pre-planned sale (10b5-1)

$101,730
Sell

Townson Sharon · Officer

2026-07-06 · 5,600 shares @ $23.25 · pre-planned sale (10b5-1)

$130,197
Sell

Townson Sharon · Officer

2026-07-06 · 400 shares @ $24.13 · pre-planned sale (10b5-1)

$9,652
Sell

Janku Filip · Officer

2026-06-30 · 5,407 shares @ $24.50 · pre-planned sale (10b5-1)

$132,472
Sell

Manning Anthony M. · Director

2026-06-29 · 10,000 shares @ $23.11

$231,100
Sell

Janku Filip · Officer

2026-06-29 · 6,000 shares @ $22.95 · pre-planned sale (10b5-1)

$137,700
Sell

Janku Filip · Officer

2026-06-24 · 30,000 shares @ $21.42 · pre-planned sale (10b5-1)

$642,681
Sell

Janku Filip · Officer

2026-06-23 · 11,845 shares @ $20.22 · pre-planned sale (10b5-1)

$239,522
Sell

Townson Sharon · Officer

2026-06-23 · 3,000 shares @ $20.00 · pre-planned sale (10b5-1)

$60,000
Sell

Champoux Jennifer · COO

2026-06-23 · 2,175 shares @ $20.00 · pre-planned sale (10b5-1)

$43,500
Sell

Townson Sharon · Officer

2026-06-17 · 3,000 shares @ $19.00 · pre-planned sale (10b5-1)

$57,000
Sell

Champoux Jennifer · COO

2026-06-17 · 2,176 shares @ $19.00 · pre-planned sale (10b5-1)

$41,344
Sell

Warmuth Markus · CEO · Director

2026-06-01 · 4,998 shares @ $19.41 · pre-planned sale (10b5-1)

$97,021
Sell

Warmuth Markus · CEO · Director

2026-06-01 · 468 shares @ $19.73 · pre-planned sale (10b5-1)

$9,232

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-06Miss -18%

Actual EPS -$0.43 · est. -$0.37 · Before open

▲ 0.6%

Day 1

-8.5%

Next 20 days

2026-05-07Miss -19%

Actual EPS -$0.45 · est. -$0.38 · Before open

▼ 2.8%

Day 1

-17.4%

Next 20 days

2026-03-17Miss -63%

Actual EPS -$0.55 · est. -$0.34 · Before open

▼ 2.0%

Day 1

+13.7%

Next 20 days

2025-11-06Beat +6%

Actual EPS -$0.33 · est. -$0.35 · Before open

▲ 5.7%

Day 1

+33.8%

Next 20 days

2025-08-07Beat +60%

Actual EPS -$0.15 · est. -$0.38 · Before open

▼ 2.9%

Day 1

+16.8%

Next 20 days

2025-05-08Beat +277%

Actual EPS $0.57 · est. -$0.32 · Before open

▲ 9.6%

Day 1

+18.7%

Next 20 days

2025-03-20Beat +903%

Actual EPS $0.27 · est. $0.03 · Before open

▲ 5.4%

Day 1

-35.6%

Next 20 days

2024-11-07Beat +38%

Actual EPS -$0.29 · est. -$0.47 · Before open

▲ 0.8%

Day 1

-1.3%

Next 20 days

Listen to the earnings call or read the full report on GLUE's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$1.0B
Next earnings2026-11-05
P/E (price to earnings)-
Forward P/E (on expected earnings)-6.3
Revenue growth (YoY)-61.3%
Earnings growth (YoY)-
Net profit margin0.0%
ROE-42.7%
Debt to equity (D/E)8%
Dividend yield-
Analyst targets (high / low)$37.00 / $25.00
Number of analysts6
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Downtrend ↘
RSI34
MA50 / MA200$15.32 / $18.25
Distance from MA200-34.1%
MACDJust crossed up
1-year high / low$25.77 / $7.09
vs. S&P 500 (6 months)-45.6%
Volume vs. average0.06×